A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to CRC
Related studies linked through entity extraction aliases.
A Study of a Urine Test to Detect Colorectal Cancer
- Status
- RECRUITING
- Phase
- N/A
Noninvasive Early Diagnosis of Colorectal Cancer Using Odor-Targeted Capture, Point-of-Care Testing, and Intelligent Analysis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
- Status
- RECRUITING
- Phase
- PHASE2
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2